If you enjoy this content, please share it with a colleague
RELATED CONTENT
June 29, 2022 — Siemens Healthineers and The Ohio State University Wexner Medical Center announced a new alliance, aimed ...
May 11, 2022 — Adaptiiv Medical Technologies is collaborating with HP Inc. and Varian, a Siemens Healthineers company ...
January 7, 2022 — Varian and parent company Siemens Healthineers have been recognized in the annual IMV ServiceTrak repo ...
May 25, 2021 — Independent verification always has been, and likely always will be, the core value proposition for RadCa ...
October 19, 2020 — Varian, a leading provider of cancer care technologies and solutions, continues to reinforce its ...
June 1, 2020 — RaySearch Laboratories AB and Varian Medical Systems have entered into an interoperability agreement that ...
David Sjostrom, Ph.D., deputy chief physicist, Herlev Hospital, Department of Oncology, Division of Radiotherapy, Herlev ...
This is a quick demonstration of the Varian Identify image-guided patient positioning system at the American Association ...
Varian announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors. When completed, this acquisition, in combination with the recent acquisitions of Endocare and Alicon, will expand Varian's portfolio of multidisciplinary integrated cancer care solutions.
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment Services International (CTSI) for $283 million. Privately held, CTSI operates the American Oncology Institute in Hyderabad and 10 multidisciplinary — radiation, medical and surgical oncology — cancer centers across the Indian subcontinent, as well as a U.S.-based Oncology Solutions division that provides cancer care professional services to healthcare providers worldwide.